Robert Fintelmann, MD
Ophthalmology · Glendale, AZNPI 1497971535
Payments from drug & device makers
Across 11 payments — averaging $353.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microsurgical Technology, Inc.$3K
- Beaver-visitec International, Inc.$900
- Carl Zeiss Meditec USA, Inc.$65
- Rxsight Inc$26
- Dompe US, Inc.$25
- Alcon$24
- plus $72 from 4 others
What the payments were for
- Consulting fees$90023%
- Speaking & faculty fees$261%
- Food & beverage$1504%
- Gifts$361%
- Charitable contribution$2,77871%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microsurgical Technology, Inc. | 1 | $2,778 |
| Beaver-visitec International, Inc. | 1 | $900 |
| Carl Zeiss Meditec USA, Inc. | 2 | $65 |
| Rxsight Inc | 1 | $26 |
| Dompe US, Inc. | 1 | $25 |
| Alcon | 1 | $24 |
| Biotissue Holdings Inc. | 1 | $22 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $17 |
| Ivantis, Inc | 1 | $16 |
| Glaukos Corporation | 1 | $16 |
How this compares
$3,889 in reported general payments places this provider in the 70th percentile of 310 ophthalmology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 18 | $11,777 |
| Prednisolone Acetate | 145 | $4,374 |
| Fluorometholone | 26 | $1,678 |
| MoxifloxacinMoxifloxacin Hcl | 75 | $1,508 |
| ValacyclovirValacyclovir Hcl | 21 | $871 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 59 | $562 |
| Dexamethasone Sodium Phosphate | 13 | $499 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $151 |
| Diclofenac Sodium | 15 | $128 |
| Azithromycin | 12 | $49 |
| Timolol Maleate | 11 | $45 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Glendale
- George ReissGlendale$1.3M
- Shamil PatelGlendale$457K
- Sara GhobraielGlendale$345K
- Wendy HuangGlendale$73K
- Anne FloydGlendale$11K
- Mark BarakatScottsdale$2.9M
- Michael DepenbuschChandler$2.3M
- Ramin SchadluPhoenix$1.8M
- Gerald WalmanSun City$1.7M
- John CasonPhoenix$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.